Literature DB >> 12455813

Hematological manifestations of rheumatoid arthritis.

S J Bowman1.   

Abstract

OBJECTIVE: To inform clinical rheumatologists about the common and rarer hematological manifestations of rheumatoid arthritis with an emphasis on diagnosis and therapy and a particular reference to Felty's syndrome.
METHODS: Literature review.
RESULTS: The hematological manifestations can be conveniently categorized into the broad areas of; anemia, particularly NSAID induced iron deficiency anemia and the anemia of chronic disease, neutropenia, particularly Felty's syndrome and the large granular lymphocyte syndrome and drug induced neutropenia; thrombocytopenia, particularly autoimmune and drug induced thrombocytopenia; and hematological malignancy. Rarer conditions, their diagnosis and therapy are also described in this review.
CONCLUSION: Hematological manifestations of rheumatoid arthritis are very common. A logical approach using easily available tests should allow straightforward decisions about diagnosis and therapy to be made, even in patients with some of the rarer manifestations.

Entities:  

Mesh:

Year:  2002        PMID: 12455813     DOI: 10.1080/030097402760375124

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  16 in total

Review 1.  [Rheumatic and hemato-/oncological disorders].

Authors:  M A Reuss-Borst
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

2.  Clinical features and pathological joint changes in dogs with erosive immune-mediated polyarthritis: 13 cases (2004-2012).

Authors:  Magen L Shaughnessy; Susannah J Sample; Carter Abicht; Caitlin Heaton; Peter Muir
Journal:  J Am Vet Med Assoc       Date:  2016-11-15       Impact factor: 1.936

3.  Extra-articular Manifestations in Rheumatoid Arthritis.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie; R Tanasescu
Journal:  Maedica (Buchar)       Date:  2010-12

Review 4.  [Link between rheumatoid arthritis and cancer].

Authors:  P Whelan
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

5.  Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia.

Authors:  Ozlem Cırpan Ayvaz; Irfan Yavasoglu; Gurhan Kadikoylu; Gokay Bozkurt; Zahit Bolaman
Journal:  Rheumatol Int       Date:  2011-01-18       Impact factor: 2.631

6.  Novel acetamide derivatives of 2-aminobenzimidazole prevent inflammatory arthritis in rats via suppression of pro-inflammatory mediators.

Authors:  Aymun Madni Zubair; Muhammad Nasir Hayat Malik; Waqas Younis; Muhammad Atif Hayat Malik; Shah Jahan; Ishtiaq Ahmed; Alamgeer Yuchi; Muhammad Naveed Mushtaq; Romeeza Tahir; Muhammad Bilal Sarwar; Muhammad Roman; Ayaz Ali Khan; Muhammad Nouman Tahir; Muhammad Tariq Khan; Hafiz Amir Ali Kharl; Gagun Kamran; Abdullah Abdo Albegali; Ali Imran
Journal:  Inflammopharmacology       Date:  2022-04-16       Impact factor: 4.473

7.  Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis.

Authors:  Inés Colmegna; Alejandro Diaz-Borjon; Hiroshi Fujii; Linda Schaefer; Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Rheum       Date:  2008-04

8.  Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis.

Authors:  Hae-Rim Kim; Kyoung-Woon Kim; So-Young Yoon; Sang-Hyon Kim; Sang-Heon Lee
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

9.  α-Mangostin Alleviated Inflammation in Rats With Adjuvant-Induced Arthritis by Disrupting Adipocytes-Mediated Metabolism-Immune Feedback.

Authors:  Ying-Hao Hu; Jun Han; Lin Wang; Chao Shi; Yan Li; Opeyemi Joshua Olatunji; Xiu Wang; Jian Zuo
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.810

10.  Diffuse disseminated candidiasis in a patient with Felty's syndrome: a case report.

Authors:  Shany Ish-Hurwitz; Zamir Dovrish; Evgeny Edelstein; Joelle Bernheim; Jack Bernheim; Ruth Hadari; Howard Amital
Journal:  Rheumatol Int       Date:  2007-06-19       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.